Skip to content

Evaluation of the Efficacy to Accelerate Skin Repair after SDS-Induced Skin Irritation and Evaluation of the Protective Efficacy of Protective Cream WO 3133

Evaluation of the Efficacy to Accelerate Skin Repair after SDS-Induced Skin Irritation and Evaluation of the Protective Efficacy of Protective Cream WO 3133

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009497
Enrollment
30
Registered
2015-10-15
Start date
2012-04-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidermal barrier damage / skin irritation

Interventions

Group 1: Test area: During the first phase (Day 1–7), the test area was washed once daily with 5% SDS solution. During the second phase (Day 9-14) the product (Protective Cream WO 3313) was applied tw

Sponsors

Dr. August Wolff GmbH & Co. KG Arzneimittel
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinically healthy

Exclusion criteria

Exclusion criteria: Skin diseases, pregnancy

Design outcomes

Primary

MeasureTime frame
Skin regeneration in the test area compared to control area after SDS-induced irritation. Test parameters: skin hydration (Corneometer), transepidermal water loss (Tewameter), skin redness (Chromameter) and skin roughness (PRIMOS measuring system). Measurements: 12-14 hours after product application on day 10, 12, and 15.

Secondary

MeasureTime frame
Skin protection against SDS-induced irritation in the test area compared to control area. Test parameters: skin hydration (Corneometer), transepidermal water loss (Tewameter), skin redness (Chromameter) and skin roughness(PRIMOS measuring system). Measurements: 5-6 hours after product application on day 17, 19, and 21.

Countries

Germany

Contacts

Public ContactBoris Nissen

Derma Consult Concept GmbH

bonissen@dermaconsult.de0228-30890-11

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026